<DOC>
	<DOCNO>NCT00119119</DOCNO>
	<brief_summary>The fibrosis liver complication chronic hepatitis C. There actually establish treatment fibrosis liver . Pentoxyphilline tocopherol may activity fibrosis . The aim study analyse efficacy safety combination pentoxyphilline tocopherol ( 12 month ) liver fibrosis , patient chronic hepatitis C , non-long-term responder , intolerance contra-indication interferon-alfa ribavirin .</brief_summary>
	<brief_title>Efficacy Safety Pentoxyphilline Tocopherol Fibrosis Patients With Chronic Hepatitis C</brief_title>
	<detailed_description>The aim study analyse efficacy safety combination pentoxyphilline ( 400 mg , twice day ) tocopherol ( 500 mg , twice day ) , give 12 month fibrosis relate HCV chronic hepatitis 100 patient non-long-term responder , contra-indication intolerance current treatment reference ( combination interferon-alfa ribavirin ) . It therapeutic , national , multicentric , double-blind , placebo-controlled phase III trial . The patient include histological liver injury Metavir score A 0 2 , F 2 3 etiology liver disease . The primary objective analyse variation liver fibrosis evaluate morphometric analysis 2 liver biopsy perform end trial within 3 year treatment . The secondary objective variation Metavir fibrosis activity score , serum marker fibrosis ( hyaluronate , PIIIP , TNF-alfa , fibrotest ) ALT end begin treatment .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Age 18 75 year Chronic hepatitis C define positive HCV Ab HCV RNA histological proven injury Liver biopsy size equal 15mm , perform within 3 year enrolment , Metavir score activity 0 2 fibrosis score 2 3 . Non long term responder patient contraindication intolerance interferon alfa ribavirin No antiviral treatment trial Signed write informed consent Alcohol consumption equal 40 g/d Allergy tocopherol pentoxyphilline Treatment platelet antiaggregates , antivitamin K , theophylline , armophylline Treatment tocopherol pentoxyphilline since last liver biopsy Pregnancy , breast feeding , lack contraception Decompensated cirrhosis , organ graft , chronic renal insufficiency BMI 27 Diabetes type I II Other etiology liver disease ( HBV , HIV , hemochromatosis , alfa1 antitrypsin deficiency , Wilson â€™ disease , autoimmune hepatitis , drugrelated hepatitis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>Tocopherols</keyword>
</DOC>